John R Fischer

PE spots opportunity in surgical equipment: 5 deals

PAI Partners, Grovecourt Capital and HealthEdge are among the PE firms investing in surgical equipment manufacturers and distributors.

How PE healthcare investors are navigating M&A regulations state by state

Reed Smith's Brian Bewley is concerned that 'that this patchwork of state laws restricting or eliminating PE investments in healthcare will have a serious impact on innovation.'

PE spots opportunity in mental and behavioral health; New Mountain forms RCM platform via three-way merger

Recapping a seven-deal listicle on mental and behavioral healthcare, which has caught the attention of KKR, Clearview Capital, Northlane Capital Partners, and Sovereign Capital Partners, among others; shining the light on a three-way platform merger by New Mountain Capital in revenue cycle management.

Mental and behavioral healthcare draws in PE interest: 7 deals

KKR, Clearview Capital and Northlane Capital Partners are among the PE firms pursuing deals in mental and behavioral healthcare.

Crescera Capital, Knox Lane, Leeds target healthcare education; Dental industry tariff, recession resistant, says Houlihan Lokey panel

Cressey & Company's investment in Paradigm Health, a hospice and palliative care services provider, in spotlight.

PE taps into healthcare education: 5 deals

Hayfin Capital, Knox Lane and Leeds Equity Partners are among the PE firms investing in healthcare education.

Why private equity firms are investing in clinical trial management systems

Nordic Capital and Riverside see investment opportunities in interoperability, automation and compliance software for global clinical trials.

Astorg, BayPine, Blackstone bet on pharma CRO tailwinds; Frazier Healthcare Partners heads east with New York office opening

A roundup of five deals to showcase the scaling potential for investments in the pharma contract research organizations space; Seattle-based Frazier Healthcare Partners is aiming to scale up their businesses with the opening of a New York office this summer, and PE Hub, as part of its Dealmakers to Watch series, speaks with office head Philip Zaorski about how an East Coast office will help the firm; looking at several deals covered by PE Hub in the mental health space.

Pharma CROs draw in PE interest: 5 deals

Astorg, BayPine, Blackstone and InTandem Capital Partners are targeting the CRO sector for investments.

Frazier Healthcare’s Philip Zaorski eyes New York’s talent pool of PE pros, bankers and LPs

Zaorski is moving from Seattle, where Frazier Healthcare is headquartered, to New York to head the firm's new midtown Manhattan office.